{
    "2020-10-13": [
        [
            {
                "time": "2023-10-10",
                "original_text": "Why Abbott (ABT) is Poised to Beat Earnings Estimates Again",
                "features": {
                    "keywords": [
                        "Abbott",
                        "earnings estimates",
                        "poised"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-10",
                "original_text": "Another Abbott antibody test is authorized",
                "features": {
                    "keywords": [
                        "Abbott",
                        "antibody test",
                        "authorized"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-10",
                "original_text": "The Zacks Analyst Blog Highlights: Visa, Walmart, Abbott Laboratories, UnitedHealth Group and Oracle",
                "features": {
                    "keywords": [
                        "Zacks Analyst Blog",
                        "Visa",
                        "Walmart",
                        "Abbott Laboratories",
                        "UnitedHealth Group",
                        "Oracle"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "technology",
                        "retail",
                        "finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-10",
                "original_text": "Abbott's New Antibody Test Gets FDA's EUA, Test Suite Expands",
                "features": {
                    "keywords": [
                        "Abbott",
                        "antibody test",
                        "FDA",
                        "EUA",
                        "test suite expands"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}